现在的位置: 首页时讯速递, 进展交流>正文
[JAMA发表论文]:急诊科启动的缓和医疗照护
2025年03月24日 时讯速递, 进展交流 [JAMA发表论文]:急诊科启动的缓和医疗照护已关闭评论

Original Investigation 

January 15, 2025

Palliative Care Initiated in the Emergency Department: A Cluster Randomized Clinical Trial

Corita R. Grudzen, Nina Siman, Allison M. Cuthel, et al

JAMA. Published online January 15, 2025. doi:10.1001/jama.2024.23696

Key Points

Question  What is the effect of a multicomponent intervention to initiate palliative care in the emergency department on hospital admission in older adults with serious, life-limiting illness?

Findings  In this cluster randomized clinical trial, which was conducted at 29 US emergency departments and included 98 922 initial visits, there was no difference in the rate of hospital admission in older adults with serious, life-limiting illness receiving care before (64.4%) vs after (61.3%) emergency department clinical staff receipt of a multicomponent primary palliative care intervention.

Meaning  A multicomponent primary palliative care intervention did not have an effect on hospital admission in older adults with serious, life-limiting illness.

Abstract

Importance  The emergency department (ED) offers an opportunity to initiate palliative care for older adults with serious, life-limiting illness.

Objective  To assess the effect of a multicomponent intervention to initiate palliative care in the ED on hospital admission, subsequent health care use, and survival in older adults with serious, life-limiting illness.

Design, Setting, and Participants  Cluster randomized, stepped-wedge, clinical trial including patients aged 66 years or older who visited 1 of 29 EDs across the US between May 1, 2018, and December 31, 2022, had 12 months of prior Medicare enrollment, and a Gagne comorbidity score greater than 6, representing a risk of short-term mortality greater than 30%. Nursing home patients were excluded.

Intervention  A multicomponent intervention (the Primary Palliative Care for Emergency Medicine intervention) included (1) evidence-based multidisciplinary education; (2) simulation-based workshops on serious illness communication; (3) clinical decision support; and (4) audit and feedback for ED clinical staff.

Main Outcome and Measures  The primary outcome was hospital admission. The secondary outcomes included subsequent health care use and survival at 6 months.

Results  There were 98 922 initial ED visits during the study period (median age, 77 years [IQR, 71-84 years]; 50% were female; 13% were Black and 78% were White; and the median Gagne comorbidity score was 8 [IQR, 7-10]). The rate of hospital admission was 64.4% during the preintervention period vs 61.3% during the postintervention period (absolute difference, −3.1% [95% CI, −3.7% to −2.5%]; adjusted odds ratio [OR], 1.03 [95% CI, 0.93 to 1.14]). There was no difference in the secondary outcomes before vs after the intervention. The rate of admission to an intensive care unit was 7.8% during the preintervention period vs 6.7% during the postintervention period (adjusted OR, 0.98 [95% CI, 0.83 to 1.15]). The rate of at least 1 revisit to the ED was 34.2% during the preintervention period vs 32.2% during the postintervention period (adjusted OR, 1.00 [95% CI, 0.91 to 1.09]). The rate of hospice use was 17.7% during the preintervention period vs 17.2% during the postintervention period (adjusted OR, 1.04 [95% CI, 0.93 to 1.16]). The rate of home health use was 42.0% during the preintervention period vs 38.1% during the postintervention period (adjusted OR, 1.01 [95% CI, 0.92 to 1.10]). The rate of at least 1 hospital readmission was 41.0% during the preintervention period vs 36.6% during the postintervention period (adjusted OR, 1.01 [95% CI, 0.92 to 1.10]). The rate of death was 28.1% during the preintervention period vs 28.7% during the postintervention period (adjusted OR, 1.07 [95% CI, 0.98 to 1.18]).

Conclusions and Relevance  This multicomponent intervention to initiate palliative care in the ED did not have an effect on hospital admission, subsequent health care use, or short-term mortality in older adults with serious, life-limiting illness.

Trial Registration  ClinicalTrials.gov Identifier: NCT03424109

抱歉!评论已关闭.

×
腾讯微博